Datopotamab Deruxtecan
82921

TargetTACSTD2
Product group Antibodies
Overview
- SupplierBPS Bioscience
- Product NameDatopotamab Deruxtecan
- Delivery Days Customer23
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity≥90%
- Gene ID4070
- Target nameTACSTD2
- Target descriptiontumor associated calcium signal transducer 2
- Target synonyms40kD glycoprotein, identified by monoclonal antibody GA733; cell surface glycoprotein TROP2; cell surface glycoprotein Trop-2; EGP1; EGP-1; epithelial glycoprotein-1; GA7331; GA733-1; gastrointestinal tumor-associated antigen GA7331; GP50; M1S1; membrane component, chromosome 1, surface marker 1; pancreatic carcinoma marker protein GA7331; pancreatic carcinoma marker protein GA733-1; TROP2; trophoblast cell surface antigen 2; truncated TACSTD2; tumor-associated calcium signal transducer 2
- Protein IDP09758
- Protein NameTumor-associated calcium signal transducer 2
- Scientific DescriptionDatopotamab deruxtecan (DS-1062; Dato-DXd) is a trophoblast cell surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC). Datopotamab deruxtecan has a potent antitumor activity.1
- Storage Instruction-80°C
- UNSPSC12352203